Skip to main content

Articles

Page 8 of 369

  1. Systemic inflammation has prognostic value in cancer and is considered aetiological of cachexia by the Global Leadership Initiative on Malnutrition (GLIM). Lactate dehydrogenase (LDH) also has recognized progn...

    Authors: Joshua J. Thompson, Nicholas MacLeod, Sarah Will, Fraser O’Rourke, Josh McGovern, Campbell Roxburgh, Joanne Edwards, Ross D. Dolan and Donald C. McMillan
    Citation: BMC Cancer 2025 25:543
  2. The role of sodium-glucose co-transporter 2 inhibitor (SGLT2i) drugs in the management of diabetes and cardiovascular disease is well-established, but emerging evidence suggests potential effects on cancer out...

    Authors: Lucas E. Flausino, Alexis Germán Murillo Carrasco, Tatiane Katsue Furuya, Wen-Jan Tuan and Roger Chammas
    Citation: BMC Cancer 2025 25:542
  3. Immune checkpoint inhibitors (ICIs) have revolutionized treatment for advanced lung cancer, yet their cardiotoxicity, particularly immune checkpoint inhibitor-related myocarditis, poses significant clinical ch...

    Authors: Shanshan Li, Feng Du, Yan Zhang, Qiang Wang, Jianjian Dou and Xiangjiao Meng
    Citation: BMC Cancer 2025 25:541
  4. Claudin 18.2 (CLDN18.2), a tight junction protein predominantly expressed in the normal gastric epithelium, has recently emerged as a potential therapeutic target in various solid tumors. Despite growing inter...

    Authors: Nah Ihm Kim, Joo Yeon Koo, Sung Sun Kim, Ji Young Lee, Ji Shin Lee, Hyun Jin Bang, Woo Kyun Bae, Tae Mi Yoon, Kyung-Sub Moon, Jae-Hyuk Lee and Kyung-Hwa Lee
    Citation: BMC Cancer 2025 25:540
  5. Systemic inflammation and nutritional status are key factors affecting the prognosis of patients with cancer cachexia. This study aims to evaluate the prognostic value of a new nutritional and inflammatory ind...

    Authors: Xiangrui Li, Li Deng, Hailun Xie, Shuqun Li, Hong Zhao, Tong Liu, Xiaoyue Liu, Shiqi Lin, ChengAn Liu and Han-Ping Shi
    Citation: BMC Cancer 2025 25:539
  6. In view of inherent attributes of breast BI-RADS 3, benign and malignant lesions are with a subtle difference and the imbalanced ratio (with a very small part of malignancy). The objective of this study is to ...

    Authors: Huanhuan Tian, Li Cai, Yu Gui, Zhigang Cai, Xianfeng Han, Jianwei Liao, Li Chen and Yi Wang
    Citation: BMC Cancer 2025 25:537
  7. In this study, we retrospectively analyzed the incidence of and risk factors for in-hospital venous thromboembolism (VTE) in patients with bladder cancer and explored measures to reduce the incidence of and/or...

    Authors: Huitang Yang, Tonghe Zhang, Zhaoyang Li, Yandong Cai, Zhan Jiang, Guoju Fan, Kaiqiang Wang, Bo Chen, Hongwei Zhang, Hailong Hu and Yankui Li
    Citation: BMC Cancer 2025 25:536
  8. Despite advancements in the detection and treatment of prostate cancer, the molecular mechanisms underlying its progression remain unclear. This study aimed to investigate the role of the receptor OR51E2, whic...

    Authors: Mikkel Thy Thomsen, Morten Busk, Dalin Zhang, Chun-Lung Chiu, Hongjuan Zhao, Fernando Jose Garcia-Marques, Abel Bermudez, Sharon Pitteri, Michael Borre, James D. Brooks and Jens Randel Nyengaard
    Citation: BMC Cancer 2025 25:535
  9. Psoriasis is a chronic inflammatory skin condition mediated by autoimmune processes, which may heighten the susceptibility to infections. However, its impact on infection risk and survival outcomes in patients...

    Authors: Lin Jian, Mu-Kuan Chen, Chew-Teng Kor and Yen-Tze Liu
    Citation: BMC Cancer 2025 25:534
  10. This study aimed to elucidate the expression profile and biological implications of peroxidase 5 (PRDX5) in bladder cancer (BC), specifically investigating its influence on BC progression through modulation of...

    Authors: Shun Wan, Kun-peng Li, Si-yu Chen, Chen-yang Wang, Kun Cheng, Jian-wei Yang, Li-yun Ding, Tuan-jie Che, Shan-hui Liu and Li Yang
    Citation: BMC Cancer 2025 25:533
  11. Haematological cancer affects more than 1.3 million people around the world annually and accounted for almost 800,000 deaths globally in 2020. The number of patients with these cancers undergoing bone marrow t...

    Authors: Linda Denehy, Shaza Abo, Christopher Swain, Camille E. Short, Nicole Kiss, Amit Khot, Eric Wong, Duncan Purtill, Clare O’Donnell, Marlena Klaic, Catherine L. Granger, Michelle Tew, Tim Spelman, Vinicius Cavalheri and Lara Edbrooke
    Citation: BMC Cancer 2025 25:532
  12. There is a lack of consensus among physicians working in the field of disability assessment about the definition of a limited life expectancy. The aim of this study was to describe the mortality rate of employ...

    Authors: Jetske A. Kraan, Michiel A. Greidanus, Sietske J. Tamminga and Jan L. Hoving
    Citation: BMC Cancer 2025 25:531
  13. Tenosynovial giant cell tumour (TGCT) is one of the most prevalent soft tissue tumours of the foot and ankle. Although typically benign, it can exhibit locally aggressive behaviour. This study aims to evaluate...

    Authors: Christian Scheele, Norbert Harrasser, Simone Beischl, Dietmar Dammerer, Ulrich Lenze, Carolin Knebel, Rüdiger von Eisenhart-Rothe and Florian Lenze
    Citation: BMC Cancer 2025 25:530

    The Correction to this article has been published in BMC Cancer 2025 25:627

  14. To evaluate the efficacy and safety of track sealing using subpleural injection of gelatin sponge particles in reducing the incidence of pneumothorax after percutaneous CT-guided lung biopsy.

    Authors: Zi-Yi Zhu, Ya-Qin Yun, Hao Li, Zhong-Qiang Qin, Zhen Qian, Yun Zhu, Shu-Hua Li, Bo Xie and Mu Yuan
    Citation: BMC Cancer 2025 25:529
  15. Approximately 50% of ovarian cancer (OC) survivors report fear of cancer recurrence/progression (FCR/P) as the most challenging aspect of living with cancer. This pilot, randomised waitlist-controlled trial ai...

    Authors: Verena S Wu, Allan ‘Ben’ Smith, Hayley Russell, Adeola Bamgboje-Ayodele, Lisa Beatty, Alison Pearce, Haryana Dhillon, Joanne Shaw, Jan Antony, Joanna Fardell, Anupama Pangeni, Cyril Dixon, Orlando Rincones, Laura Langdon, Daniel Costa and Afaf Girgis
    Citation: BMC Cancer 2025 25:527
  16. Image-guided superficial radiation therapy (IGSRT) using a high resolution dermal ultrasound, is becoming a non-surgical highly effective treatment option for non-melanoma skin cancer (NMSC). In a previous stu...

    Authors: Mairead Moloney, Peyton M. Harris, Peter Kaczmarski, Songzhu Zheng, Daniel Ladd, Donna Serure, Ariana Malik and Lio Yu
    Citation: BMC Cancer 2025 25:526
  17. The Xizang Autonomous Region, located in China’s southwestern frontier with an average elevation of 4000 m, faces socioeconomic development challenges influenced by its natural environment and regional dispari...

    Authors: Pingcuo Zhuoma, Gama Cangjue, Hui Wang and Jinlei Qi
    Citation: BMC Cancer 2025 25:525
  18. Salvage high-dose-rate brachytherapy (HDR-BT) is a potential treatment for localized recurrence of prostate cancer following definitive radiation therapy. This study aimed to evaluate the long-term safety and ...

    Authors: Kenta Watanabe, Nobuhiko Kamitani, Naoki Ikeda, Yujiro Kawata, Ryoji Tokiya, Takafumi Hayashi, Yoshiyuki Miyaji, Tsutomu Tamada and Kuniaki Katsui
    Citation: BMC Cancer 2025 25:524
  19. Accurately assessing the prognosis of bladder cancer patients after radical cystectomy has important clinical and research implications. Current models, based on traditional statistical approaches and complex ...

    Authors: Lei Dai, Kun Ye, Gaosheng Yao, Juan Lin, Zhiping Tan, Jinhuan Wei, Yanchang Hu, Junhang Luo, Yong Fang and Wei Chen
    Citation: BMC Cancer 2025 25:523
  20. NDRG1, a cell differentiation-associated factor, has recently emerged as a regulator ferroptosis. Nevertheless, its role in modulating ferroptosis within hepatocellular carcinoma (HCC) remains uncharacterized.

    Authors: Liuzheng Li, Tong Wu, Guocha Gong, Bo Li, Jiawei Feng, Leisheng Xu, Hairong Zhao and Xuechang Gao
    Citation: BMC Cancer 2025 25:522
  21. Olaparib exhibits antitumor effects in castration-resistant prostate cancer patients with germline mutations in DNA repair genes. We previously reported that simvastatin reduced the expression of DNA repair ge...

    Authors: Yoshitaka Sekine, Daisuke Oka, Akira Ohtsu, Hiroshi Nakayama, Takeshi Miyao, Yoshiyuki Miyazawa, Seiji Arai, Hidekazu Koike, Hiroshi Matsui, Yasuhiro Shibata and Kazuhiro Suzuki
    Citation: BMC Cancer 2025 25:521
  22. Predicting the response to neoadjuvant chemoimmunotherapy in patients with resectable non-small cell lung cancer (NSCLC) facilitates clinical treatment decisions. Our study aimed to establish a machine learnin...

    Authors: Xingbiao Liu, Zhilin Ji, Libo Zhang, Linlin Li, Wengui Xu and Qian Su
    Citation: BMC Cancer 2025 25:520
  23. Prognostic prediction plays a pivotal role in guiding personalized treatment for patients with locoregionally advanced nasopharyngeal carcinoma (LANPC). However, few studies have investigated the incremental v...

    Authors: Lian Jian, Cai Sheng, Huaping Liu, Handong Li, Pingsheng Hu, Zhaodong Ai, Xiaoping Yu and Huai Liu
    Citation: BMC Cancer 2025 25:519
  24. Gastric cancer (GC) is a prevalent malignancy affecting the digestive system. We aimed to develop a risk prediction model based on endoscopic atrophy classification for GC.

    Authors: Yadi Lan, Weijia Sun, Shen Zhong, Qianqian Xu, Yining Xue, Zhaoyu Liu, Lei Shi, Bing Han, Tianyu Zhai, Mingyue Liu, Yujing Sun and Hongwei Xu
    Citation: BMC Cancer 2025 25:518
  25. Dedifferentiated liposarcoma (DDLPS) is a fairly common subtype of soft tissue sarcoma, but relatively little is known about the clinical course and prognostic factors of this mesenchymal malignancy.

    Authors: Jelena Casier, Iris Timmermans, Annouschka Laenen, Daphne Hompes, Thomas Douchy, Raf Sciot, Melissa Christiaens, Hazem Wafa and Patrick Schöffski
    Citation: BMC Cancer 2025 25:517
  26. Multiple primary malignancies (MPM) are two or more independent primary malignancies. Recently, the relationship between microbiome and various tumors has been gradually focused on.

    Authors: Yinhang Wu, Zhanbo Qu, Zheng Wu, Jing Zhuang, Yingchen Wang, Zefeng Wang, Jian Chu, Quan Qi and Shuwen Han
    Citation: BMC Cancer 2025 25:516
  27. Ovarian cancer is the most lethal and third leading cause of gynaecological cancers globally and in South Africa (SA). However, its current mortality trends have not been evaluated in most sub-Saharan African ...

    Authors: Gbenga Olorunfemi, Elena Libhaber, Oliver C. Ezechi and Eustasius Musenge
    Citation: BMC Cancer 2025 25:515
  28. Head and neck cancer (HNC) survivors experience a significant financial burden (FB) after treatment, even in Germany with a statutory health insurance. The financial toxicity of cancer can cause higher morbidi...

    Authors: Jonas Rast, Veit Zebralla, Theresa Wald, Andreas Dietz, Gunnar Wichmann and Susanne Wiegand
    Citation: BMC Cancer 2025 25:514
  29. Lung cancer, a leading cause of mortality worldwide, necessitates effective therapeutic strategies. Caragana jubata, a traditional Chinese medicinal plant, harbors Texasin, a potential anti-tumor agent. This stud...

    Authors: Liuzhao Cao, Tiantian Li, Xingxiang Xu, Mei Sun, Weiyun Teng and Miao Zhu
    Citation: BMC Cancer 2025 25:513
  30. Pancreatic ductal adenocarcinoma (PDAC) is difficult to detect early and highly aggressive, often leading to poor patient prognosis. Existing serum biomarkers like CA19-9 are limited in early diagnosis, failin...

    Authors: Yingqi Xiao, Shixin Sun, Naxin Zheng, Jing Zhao, Xiaohan Li, Jianmin Xu, Haolian Li, Chenran Du, Lijun Zeng, Juling Zhang, Xiuyun Yin, Yuan Huang, Xuemei Yang, Fang Yuan, Xingwang Jia, Boan Li…
    Citation: BMC Cancer 2025 25:512
  31. Family caregivers are essential members of the care team of someone with pancreatic cancer, supporting their physical and psychological needs. Caregivers are often unprepared for this which may cause substanti...

    Authors: Tara Anderson, Gary Mitchell, Gillian Prue, Susan McLaughlin and Lisa Graham-Wisener
    Citation: BMC Cancer 2025 25:511
  32. There is a significant unmet need in treating patients with limited-stage small-cell lung cancer (LS-SCLC). The ETER701 study showed that Benmelstobart (TQB2450, an anti-PD-L1 antibody) combined with Anlotinib...

    Authors: Xiaoli Liu, Xiaoyan Yin, Lulu Zhuang, Junxu Wen, Zhonghui Wei, Wenxing Cui, Minghao Yu, Kaikai Zhao, Lanping Liu, Lingling Kong, Liyang Jiang, Xuquan Jing, Hui Zhu, Xunqiang Wang, Xinjun Dong, Jinming Yu…
    Citation: BMC Cancer 2025 25:509
  33. Interstitial pneumonitis is a potentially fatal complication of cancer-related therapy. However, data regarding the risk factors, prognosis and safety and benefit of rechallenge treatment are scarce.

    Authors: Hung-Yuan Yu, Chun-Yang Lee, Yen-Chi Hu, Le-Gin Lin, Yee Chao and Chung-Pin Li
    Citation: BMC Cancer 2025 25:508
  34. The Fc fragment of IgG binding protein (FCGBP) exhibits differential expression across various tumor types. but its role in cancer progression remains underexplored. This research discovered that FCGBP is down...

    Authors: Jiefu Wang, Ziqing Gong, Jia Liu, Wenpeng Wang, Kai Liu, Yanpeng Yang, Xinran Lu and Junfeng Wang
    Citation: BMC Cancer 2025 25:507
  35. In clinical practice, lymph node status has an important impact on colon cancer (CC) management and treatment. The role of the tumor microenvironment collagen score and immunoscore in colon cancer lymph node m...

    Authors: Chenyan Long, Jiaxin Cheng, Mingyuan Feng, Botao Yan, Yiran Li, Wei Jiang, Dexin Chen and Jun Yan
    Citation: BMC Cancer 2025 25:506
  36. Kaposi sarcoma (KS) is the commonest HIV-associated malignancy. It is caused by co-infection with Kaposi sarcoma herpesvirus (KSHV), which upregulates the MAPK pathway. The aim of the SCART trial was to identi...

    Authors: Robin J. Young, Amanda Kirkham, Joshua Savage, Charlotte Gaskell, Sarah Johnson, David H. Dockrell, Mark Bower, Sarah Westwell, Christine Bowman, Michael Leahy, Penella Woll and Lucinda Billingham
    Citation: BMC Cancer 2025 25:505
  37. Liver function, tumor burden, inflammation level, and nutritional status are critical factors influencing tumor onset, progression, and metastasis. This study sought to investigate the prognostic significance ...

    Authors: Yuhao Su, Yuxin Liang, Deyuan Zhong, Hongtao Yan, Qinyan Yang, Jin Shang, Yahui Chen and Xiaolun Huang
    Citation: BMC Cancer 2025 25:504
  38. This study assessed the global cancer burden due to occupational carcinogens (OCs) using data from Global Burden of Disease (GBD) 2021. Mortality and disability-adjusted life years (DALYs) were employed to ass...

    Authors: Binbin Zou, Ping Wu, Jianjun Chen, Juan Luo, Yanjun Lei, Qingqing Luo, Biqiong Zhu and Ming Zhou
    Citation: BMC Cancer 2025 25:503
  39. This study was conducted to evaluate the prognosis of cervical cancer in pregnancy (CCIP) and analyze the clinicopathological factors affecting the prognosis of this cancer.

    Authors: Siyuan Zeng, Xin Li, Simin Xiao, Peina Yang, Changsheng Lin, Huiling Chen, Hu Zhao and Xue Xiao
    Citation: BMC Cancer 2025 25:502
  40. Bromodomain and extra-terminal domain (BET) inhibitors (BETi) have demonstrated epigenetic modulation capabilities, specifically in transcriptional repression of oncogenic pathways. Preclinical assays suggest ...

    Authors: Daniel Marbach, Jurriaan Brouer-Visser, Laura Brennan, Sabine Wilson, Iakov I. Davydov, Nicolas Staedler, José Duarte, Iris Martinez Quetglas, Eveline Nüesch, Marta Cañamero, Evelyne Chesné, George Au-Yeung, Erika Hamilton, Stephanie Lheureux, Debra L. Richardson, Iben Spanggaard…
    Citation: BMC Cancer 2025 25:500
  41. Hyperleukocytic acute myeloid leukemia (HLL) is marked by high early mortality and presents significant therapeutic challenges. Research on HLL is still in its infancy, and comprehensive development of patient...

    Authors: Yanxia Jin, Yuxing Liang, Balu Wu, Sanyun Wu, Xiaoyan Liu and Fuling Zhou
    Citation: BMC Cancer 2025 25:499
  42. In recent years, immunotherapy has made significant progress. However, the understanding of the heterogeneity and function of T cells, particularly CD8 + T cells, in cervical cancer (CESC) microenvironment rem...

    Authors: Rongbin Zhou, Yuli Xie, Zuheng Wang, Zige Liu, Wenhao Lu, Xiao Li, Chunmeng Wei, Xing Li and Fubo Wang
    Citation: BMC Cancer 2025 25:498
  43. The potential of medical imaging to non-invasively assess intratumoral heterogeneity (ITH) is increasingly being recognized. This study aimed to investigate the value of the ITH-based deep learning model for p...

    Authors: Shaoming Song, Gong Zhang, Zhiyuan Yao, Ruiqiu Chen, Kai Liu, Tianchen Zhang, Guineng Zeng, Zizheng Wang and Rong Liu
    Citation: BMC Cancer 2025 25:497
  44. The current understanding of the prognostic value of routine pre-treatment laboratory parameters in patients with high-risk soft tissue sarcoma (HR-STS) is limited. We sought to analyze several inflammatory bi...

    Authors: Luc M. Berclaz, Dorit Di Gioia, Vindi Jurinovic, Michael Völkl, Sinan E. Güler, Markus Albertsmeier, Alexander Klein, Hans Roland Dürr, Sina Mansoorian, Thomas Knösel, Wolfgang G. Kunz, Michael von Bergwelt-Baildon, Lars H. Lindner and Anton Burkhard-Meier
    Citation: BMC Cancer 2025 25:496
  45. The cytological diagnostic process of EUS-FNA smears is time-consuming and manpower-intensive, and the conclusion could be subjective and controversial. Moreover, the relative lack of cytopathologists has limi...

    Authors: Dong Fang, Yigeng Huang, Suwen Li, Chen Shi, Junjun Bao, Dandan Du, Lanlan Xuan, Leping Ye, Yanping Zhang, ChengLin Zhu, Hailun Zheng, Zhenwang Shi, Qiao Mei and Huanqin Wang
    Citation: BMC Cancer 2025 25:495

Featured videos

View featured videos from across the BMC-series journals